Medical/Pharmaceuticals
Ascentage Pharma Received Clearance from U.S. FDA to Proceed with Global Registrational Phase III Clinical Trial for Lisaftoclax (APG-2575) in Previously Treated Patients with CLL/SLL
ROCKVILLE, Md. and SUZHOU, China, Aug. 6, 2023 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that lisaftoclax (APG-2575), a novel Bcl-2 inhibitor...
2023-08-07 09:43
1844
VenusP-Valve granted IDE approval for clinical trial, unveiling a new chapter for Chinese valve solutions globally
HANGZHOU, China, Aug. 7, 2023 /PRNewswire/ -- Recently, Venus Medtech (Hangzhou ) Inc. ("Venus Medtech"), a leading provider of integrated solutions for transcatheter structural heart valvular therapies inChina, announced the Investigational Device Exemption (IDE) full approval for its in-house de...
2023-08-07 08:20
2914
Inaugural World NTM Awareness Day Marks 20-Year Anniversary and Honors Founders' Mission on August 4, 2023
MIAMI, Aug. 4, 2023 /PRNewswire/ -- NTM Info & Research (www.ntminfo.org), a pioneering global organization committed to addressing NonTuberculous Mycobacterial (NTM) and improving respiratory health, proudly announces the first-ever World NTM Awareness Day, to be held onAugust 4, 2023. This sig...
2023-08-04 20:26
2693
AI+ Media Development Platform AlfaOPA™ Officially Launched
HONG KONG, Aug. 4, 2023 /PRNewswire/ -- Today, the Future Technology: AI Empowering Bioprocessing Development summit hosted by Great Bay Bio (hereinafter referred to as "GBB") was successfully held at the Suzhou International Expo Center, where industry players gathered to celebrate the feast of...
2023-08-04 11:13
3509
Shenzhen to Foster Quantitative Biology Stronghold
SHENZHEN, China, Aug. 3, 2023 /PRNewswire/ -- An international conference on quantitative biology was held recently inSouthern China's Shenzhen, drawing over 300 participants from more than 20 universities worldwide to discuss illuminating opportunities and shaping the future of quantitative and ...
2023-08-03 19:00
1628
JinMed's Nanobathing Products Receive Multiple Patent Certifications and Sign Directed Procurement Agreement with Shanghai Zhongjin HongKang Medical Technology
CHANGZHOU, China, Aug. 3, 2023 /PRNewswire/ -- Jin Medical International Ltd. ("the Company" or "JinMed") (NASDAQ: ZJYL) which is the world's leading provider of rehabilitation equipment. Currently, the Company's nanobathing products have been granted an invention patent and four utility model pa...
2023-08-03 17:13
1152
SayHeart Announces AI-Powered Visual-to-Text Transformation Pilot Testing for Dental X-Rays, with Kindlehouse Dentistry Partnership
KUALA LUMPUR, Malaysia, Aug. 3, 2023 /PRNewswire/ -- SayHeart, the groundbreaking health tech firm, is excited to announce the beginning of its pilot testing phase for a revolutionary visual-to-text transformation feature, focusing on dental X-ray images. This advanced AI-driven solution is aimed...
2023-08-03 12:40
2611
Interest in Ayurvedic beauty surges, but 1 in 5 Indian consumers find it old-fashioned
MUMBAI, India, Aug. 3, 2023 /PRNewswire/ -- Ayurveda, a centuries-old system of medicine originating inIndia, has witnessed a resurgence in popularity due to heightened consumer interest in self-care. However, the latest research from Mintel reveals that 1 in 5 Indian consumers still consider Ayu...
2023-08-03 12:30
1644
Public Medicare Group Sdn Bhd and Dr. Chieng King Chong Win Fast Enterprise and Master Entrepreneur Accolades at the Asia Pacific Enterprise Awards 2023 Malaysia
SINGAPORE, Aug. 3, 2023 /PRNewswire/ -- Renowned Malaysian healthcare provider Public Medicare Group Sdn Bhd (PMG) celebrates a remarkable double triumph at the prestigious Asia Pacific Enterprise Awards (APEA) 2023 Malaysia. The company has been honored with the distinguished Fast Enterprise Awa...
2023-08-03 11:55
1677
ESMO 2023 | Ascentage Pharma to Present Results from Two Clinical Studies, including One Oral Presentation, at 2023 ESMO Congress
SUZHOU, China, and ROCKVILLE, Md., Aug. 2, 2023 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that it is going to release results from two clinic...
2023-08-03 11:43
1346
SK Biopharmaceuticals Assembles 'Board of Prominent Experts' to Boost Growth, Innovation
Renowned oncologist Yung-Jue Bang, M.D., Ph.D., chairs the distinguished 5-member Scientific Advisory Board to further advance SK Biopharmaceuticals as a global big biotech SEOUL, South Korea, Aug. 2, 2023 /PRNewswire/ -- SK Biopharmaceuticals, a global biotech company, announced the formation o...
2023-08-03 07:30
1416
Arbele announces early safety data for novel CDH17xCD3 bispecific T-cell engager at American Society of Clinical Oncology Breakthrough Meeting
SYDNEY, Aug. 2, 2023 /PRNewswire/ -- Arbele, a clinical-stage biotechnology company developing novel immunotherapies targeted for advanced gastrointestinal cancers, presented early safety data from its first-in-class CDH17xCD3 bispecific T-cell engager antibody, ARB202, at the ASCO Breakthrough c...
2023-08-03 07:00
1307
U.S. FDA Grants Orphan Drug Designation to ABM-1310 for the Treatment of Patients with Glioblastoma Harboring BRAF V600 Mutation
SAN DIEGO and SHANGHAI, Aug. 2, 2023 /PRNewswire/ -- ABM Therapeutics (ABM) announced today that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to ABM-1310, a novel small molecule BRAF inhibitor developed by the company, for the treatment of patients with g...
2023-08-03 00:00
1266
3B Scientific acquires Lifecast Body Simulation
HAMBURG, Germany, Aug. 2, 2023 /PRNewswire/ -- 3B Scientific, a leading manufacturer and marketer of medical simulation products and anatomical models for healthcare education, announces today that it has reached an agreement to acquire Lifecast Body Simulation. Launched in 2017, Lifecast ...
2023-08-02 15:00
1930
Atantares has Completed Two Rounds of RMB100 Million Financing, and the Pre-A Round is led by Asia Green Fund
BEIJING, Aug. 2, 2023 /PRNewswire/ -- Recently, Atantares announced the completion of Pre-A and Pre-A+ financing all aroundRMB100 million. The Pre-A round is led by Asia Green Fund, followed by Fosun Health Capital and existing investors Frees Fund, Qiming Venture Partners, Next Capital, and NeuX...
2023-08-02 14:56
1780
Unlocking the Power of Genetics: Camtech Unveils DNA Self-Test Kits for Holistic Wellness
SINGAPORE, Aug. 2, 2023 /PRNewswire/ -- Camtech Diagnostics, a provider of
innovative healthcare testing solutions, is excited to announce the launch of
its Ideal Health DNA Test
2023-08-02 14:42
1755
NAVI CLOSES $2.4 MILLION FOR ITS BREAKTHROUGH MEDICAL DEVICE TO HELP CRITICALLY ILL NEWBORN BABIES
Key points: * After a successful raise Navi Medical Technologies has closed a $2.4 million round of funding, which included a$700,000 lead investment from Breakthrough Victoria. * The company's innovative Neonav® ECG Tip Location System is designated as a Breakthrough medical device by the U...
2023-08-02 08:00
1862
Selected for oral presentation! Kelun-Biotech to announce latest clinical study results of SKB264 (MK-2870, TROP2-ADC) for treatment of HR+/HER2- breast cancer at ESMO Congress 2023
CHENGDU, China, Aug. 1, 2023 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech", HKEX: 6990.HK) announced that it will present the data from a Phase I/II clinical trial of the innovative TROP2-ADC (SKB264, MK-2870) jointly developed by Kelun-Biotech and MSD (the t...
2023-08-01 21:07
2537
Lunit Presents Groundbreaking Study on Predicting Treatment Response by HER2 Analysis in Colorectal Cancer
- Collaborative study with NCCHE shows that AI analysis of HER2 expression and the tumor microenvironment is linked to treatment response of Pertuzumab+Trastuzumab in colorectal cancer SEOUL, South Korea, Aug. 1, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered soluti...
2023-08-01 21:00
1696
Terumo Blood and Cell Technologies' Reveos® Automated Whole Blood Processing System Cleared by FDA for U.S. Commercial Use
Reveos is positioned to help U.S. blood centers supplement the platelet supply, reduce labor and costs, and improve overall operational efficiency LAKEWOOD, Colo., Aug. 1, 2023 /PRNewswire/ -- Terumo Blood and Cell Technologies (Terumo BCT) announces U.S. Food and Drug Administration (FDA) clear...
2023-08-01 20:30
1543
Week's Top Stories
Most Reposted
Agoda releases generative AI film to capture the joy of travel
[Picked up by 349 media titles]
2024-12-10 10:00
Mastercard Economics Institute: APAC growth expected to hold steady in 2025; global policy resets may see shift in gears
[Picked up by 313 media titles]
2024-12-10 09:00Building Asia's Future: Omni HR Secures $7.4mn for HR Tech Expansion
[Picked up by 306 media titles]
2024-12-09 10:00
CCTV+: Yuhang Journey ǀ Follow Olivier to Explore Ancient Liangzhu and Savor Jingshan Tea
[Picked up by 283 media titles]
2024-12-08 20:076th HIIFF Closes with Golden Coconut Award Ceremony
[Picked up by 282 media titles]
2024-12-11 22:19
Most Read
TEDA Celebrates 40 Years of Pioneering Innovation, Inclusive Opening-up, and Synergistic development
2024-12-07 19:16
4137
